Clarivate Launches DRG Fusion: A Platform For Commercial Analytics In Life Sciences

(RTTNews) - Clarivate Plc (CLVT), a company providing transformative intelligence, Tuesday announced that it has unveiled the launch of DRG Fusion, a cutting-edge platform designed to enhance commercial analytics in the life sciences sector.

Built by clinical and data science experts, Fusion integrates real-world data to offer biopharma and medtech organizations powerful tools to navigate complex disease and competitive landscapes, streamlining the management of raw data.

DRG Fusion addresses these challenges by offering a comprehensive suite of market data and analytics derived from integrated medical and pharmacy claims, along with other real-world data sources. This enables life sciences organizations to better understand market dynamics and make informed decisions to drive innovation.

By providing actionable insights, the platform empowers life science organizations to create a healthier tomorrow, accelerating progress in the industry.

CLVT is currently trading at $5.01 down 2.15 percent or $0.11 on the New York Stock Exchange.